Skip to main content
. Author manuscript; available in PMC: 2009 Jul 2.
Published in final edited form as: J Biomol Screen. 2008 May 19;13(5):415–423. doi: 10.1177/1087057108318331

FIG. 4.

FIG. 4

Selection of 150 compounds from primary screen. A composite z-score and a reproducibility score were assigned to each of the 50,000 compounds tested based on their ability to inhibit galactokinase (GALK) activity in vitro and the reproducibility of the 2 replicate results. The 150 compounds with a reproducibility score above 0.70 and a composite z-score greater than 7.68 were selected.